NO20092816L - Fremgangsmater for a bestemme stabiliteten av organiske metylenaminer i naervaeret av semikarbazyl-sensitiv aminoksidase - Google Patents

Fremgangsmater for a bestemme stabiliteten av organiske metylenaminer i naervaeret av semikarbazyl-sensitiv aminoksidase

Info

Publication number
NO20092816L
NO20092816L NO20092816A NO20092816A NO20092816L NO 20092816 L NO20092816 L NO 20092816L NO 20092816 A NO20092816 A NO 20092816A NO 20092816 A NO20092816 A NO 20092816A NO 20092816 L NO20092816 L NO 20092816L
Authority
NO
Norway
Prior art keywords
stability
determining
methods
semicarbazyl
methylenamines
Prior art date
Application number
NO20092816A
Other languages
English (en)
Norwegian (no)
Inventor
Adedayo Adedoyin
Michael R Angelastro
Julie Ann Bick
Jennifer Cairns
Yongqing Huang
Guyan Liang
Heng-Keang Lim
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20092816L publication Critical patent/NO20092816L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20092816A 2007-01-10 2009-08-10 Fremgangsmater for a bestemme stabiliteten av organiske metylenaminer i naervaeret av semikarbazyl-sensitiv aminoksidase NO20092816L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88426307P 2007-01-10 2007-01-10
PCT/US2008/050456 WO2008086325A1 (en) 2007-01-10 2008-01-08 Method for determining the stability of organic methyleneamines in the presence of semicarbazide-sensitive amine oxidase

Publications (1)

Publication Number Publication Date
NO20092816L true NO20092816L (no) 2009-08-10

Family

ID=39361382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092816A NO20092816L (no) 2007-01-10 2009-08-10 Fremgangsmater for a bestemme stabiliteten av organiske metylenaminer i naervaeret av semikarbazyl-sensitiv aminoksidase

Country Status (29)

Country Link
US (3) US20100028895A1 (pt)
EP (1) EP2121964A1 (pt)
JP (2) JP2010515461A (pt)
KR (1) KR20090107533A (pt)
CN (1) CN101578375B (pt)
AR (1) AR064776A1 (pt)
AU (1) AU2008204923A1 (pt)
BR (1) BRPI0806321A2 (pt)
CA (1) CA2674704A1 (pt)
CR (1) CR10862A (pt)
DO (1) DOP2009000175A (pt)
EC (1) ECSP099507A (pt)
GT (1) GT200900199A (pt)
HN (1) HN2009001289A (pt)
IL (1) IL199707A0 (pt)
MA (1) MA31226B1 (pt)
MX (1) MX2009005962A (pt)
MY (1) MY152893A (pt)
NI (1) NI200900132A (pt)
NO (1) NO20092816L (pt)
NZ (1) NZ578079A (pt)
RU (1) RU2009130380A (pt)
SG (1) SG177920A1 (pt)
SV (1) SV2009003327A (pt)
TN (1) TN2009000232A1 (pt)
TW (1) TW200907065A (pt)
UA (1) UA103300C2 (pt)
WO (1) WO2008086325A1 (pt)
ZA (1) ZA200903897B (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100533911B1 (ko) 1997-05-23 2005-12-06 바이오티에 세라피스 코포레이션 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
JP4499918B2 (ja) * 1998-03-27 2010-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高スループット・スクリーニング用の小型化マイクロタイタ・プレート
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
EP1362120A1 (en) 2001-02-23 2003-11-19 Biovitrum Ab Method for purification of soluble ssao

Also Published As

Publication number Publication date
MY152893A (en) 2014-11-28
MX2009005962A (es) 2009-06-15
AU2008204923A1 (en) 2008-07-17
HK1137784A1 (en) 2010-08-06
TW200907065A (en) 2009-02-16
EP2121964A1 (en) 2009-11-25
BRPI0806321A2 (pt) 2011-09-06
KR20090107533A (ko) 2009-10-13
US20130071870A1 (en) 2013-03-21
TN2009000232A1 (en) 2010-10-18
MA31226B1 (fr) 2010-03-01
GT200900199A (es) 2010-04-13
CR10862A (es) 2009-08-12
WO2008086325A1 (en) 2008-07-17
SV2009003327A (es) 2010-02-05
RU2009130380A (ru) 2011-02-20
JP2014204727A (ja) 2014-10-30
WO2008086325A8 (en) 2009-07-16
NI200900132A (es) 2010-03-01
AR064776A1 (es) 2009-04-22
US20100028895A1 (en) 2010-02-04
US8883410B2 (en) 2014-11-11
JP2010515461A (ja) 2010-05-13
HN2009001289A (es) 2013-02-11
UA103300C2 (ru) 2013-10-10
NZ578079A (en) 2013-02-22
IL199707A0 (en) 2010-04-15
US20140363836A1 (en) 2014-12-11
DOP2009000175A (es) 2009-07-31
CN101578375B (zh) 2012-11-07
CN101578375A (zh) 2009-11-11
SG177920A1 (en) 2012-02-28
ZA200903897B (en) 2010-04-28
ECSP099507A (es) 2009-08-28
CA2674704A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
UA116618C2 (uk) СКОНСТРУЙОВАНЕ НА ОСНОВІ ЦИСТЕЇНУ АНТИТІЛО ПРОТИ CD79b
GB2451042A (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals
WO2007114986A3 (en) Cooperative probes and methods of using them
ATE535612T1 (de) Toxizitätsscreeningverfahren
EA201992748A1 (ru) Диагностические анализы для обнаружения, количественного определения и/или отслеживания микроорганизмов и других аналитов
EP2321430B8 (en) Method of evaluating oral cancer risk in human
GB0701298D0 (en) High throughput testing for presence of microorganisms in a biological sample
CL2008000992A1 (es) Procedimiento para preparar compuestos derivados de ftalocianinas, naftalocianinas de silicio o germanio; propcedimientos para detectar e identifiar sustancias marcadoras en liquidos; compuestos de ftalocianinas de silicio.
ATE549624T1 (de) Verfahren und zusammensetzungen zur diagnose und behandlung von grippe
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
DK2005190T3 (da) Inhibering af gasc1
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей
NO20092816L (no) Fremgangsmater for a bestemme stabiliteten av organiske metylenaminer i naervaeret av semikarbazyl-sensitiv aminoksidase
DE60332183D1 (de) Methode und Apparat zur Messung von Amylase Aktivität
DE602006021131D1 (de) Verfahren zur Bestimmung des Phänotyps von Zellen
NO20081794L (no) Fremgangsmate for kvantitativ bestemmelse av poloxamere
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2007016495A3 (en) Fluorescent sensors for cellular amines
WO2007033334A3 (en) Testing compositions in a corrosive environment
WO2008030278A3 (en) Assays for radiation exposure
DE602005015108D1 (de) Methode für die Analyse von Substanzen gegen Flaviviren unter Verwendung eines persistent Virus-infizierten Zellsystems
PL383364A1 (pl) Test immunofiltracyjny do oznaczania bakterii
GR1007801B (el) Ακινητοποιηση λιπιδικων υποστρωματων με σκοπο την αναπτυξη και αξιολογηση φθορισμομετρικης μεθοδου προσδιορισμου ενεργοτητας φωσφολιπασης α2 σε βιολογικα δειγματα

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application